The United States Hospital Infection Therapeutic Market is supported by the high incidence of healthcare-associated infections, substantial healthcare spending, and increasing emphasis on reducing infection-related complications and hospital stays. Hospitals and healthcare providers are increasingly adopting advanced antibiotics, antifungal therapies, antiviral treatments, and other targeted...